Clinical trial
AtriCure Synergy Ablation Lesions for Non-Paroxysmal Forms of Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery
NCT01694563 is registered in ClinicalTrials.gov with AtriCure, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AtriCure Synergy Ablation Lesions for Non-Paroxysmal Forms of Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery
- Lead sponsor
- AtriCure, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- March 21, 2018
- Enrollment
- 365 (actual)
- Sites
- 49
Conditions
As the registry lists them; a condition with its own page is linked.
longstanding persistent atrial fibrillation, persistent atrial fibrillation